Aptorum Group Limited (NASDAQ:APM) Sees Large Growth in Short Interest

Aptorum Group Limited (NASDAQ:APM) was the target of a large growth in short interest in February. As of February 15th, there was short interest totalling 115,400 shares, a growth of 41.8% from the January 31st total of 81,400 shares. Based on an average trading volume of 2,250,000 shares, the short-interest ratio is currently 0.1 days. Currently, 2.5% of the shares of the stock are short sold.

Aptorum Group Stock Performance

NASDAQ:APM traded down $0.03 during mid-day trading on Tuesday, reaching $0.87. The stock had a trading volume of 31,672 shares, compared to its average volume of 1,204,224. The stock has a 50-day simple moving average of $1.29 and a two-hundred day simple moving average of $1.57. Aptorum Group has a 12 month low of $0.46 and a 12 month high of $17.49.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.